GT Biopharma, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
GT Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • GT Biopharma, Inc. Return On Assets for the quarter ending June 30, 2024 was -91.9 %, a 18.9% decline year-over-year.
  • GT Biopharma, Inc. annual Return On Assets for 2023 was -44.4 %, a 52.5% increase from 2022.
  • GT Biopharma, Inc. annual Return On Assets for 2022 was -93.4 %.
  • GT Biopharma, Inc. annual Return On Assets for 2020 was -1.43K %, a 381% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -44.4 +49.1 +52.5% Jan 1, 2023 Dec 31, 2023
2022 -93.4 Jan 1, 2022 Dec 31, 2022
2020 -1.43K -1.13K -381% Jan 1, 2020 Dec 31, 2020
2019 -297 -113 -61.4% Jan 1, 2019 Dec 31, 2019
2018 -184 -70.9 -62.9% Jan 1, 2018 Dec 31, 2018
2017 -113 -6.8K -102% Jan 1, 2017 Dec 31, 2017
2016 6.69K +11.9K Jan 1, 2016 Dec 31, 2016
2015 -5.17K +188 +3.52% Jan 1, 2015 Dec 31, 2015
2014 -5.36K -4.94K -1186% Jan 1, 2014 Dec 31, 2014
2013 -417 +3K +87.8% Jan 1, 2013 Dec 31, 2013
2012 -3.42K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.